Adjust Font Increase Font Decrease Font

The Catalyst

Clinical Trials – Discovering and Sharing Knowledge

Developing a new medicine to fight diseases such as cancer or diabetes can require 12-15 years of research and over $1 billion. As seen in Catalyst posts earlier this week, a foundational aspect of the research is scientifically rigorous, well-regulated clinical trials. Recently, critics such as Dr. Ben Goldacre have sought to cast doubt on [...]

Communications Breakdowns in the Scientific Community – And How to Fix Them

A colleague shared with me today an opinion piece in The Scientist that got me thinking about physicians and their hectic lives. The article delved into the communication breakdown that is occurring in the scientific community. Author David Rubenson cited several challenges, including staying up to date with the “deluge of articles coming from the [...]

Trade Groups Take Stand to Protect Drug Supply

The National Conference of Pharmaceutical Organizations (NCPO) highlighted important issues to keep the supply of medicines safe in the United States.  According to Lucinda Maine, Executive Vice President and CEO of the American Association of Colleges of Pharmacy, “ Pharmacists are taught that medication safety is their highest professional priority.  The integrity of the distribution [...]

The Spotlight

Similar to other statements below, I greatly appreciate the contribution of the PhRMA Foundation towards my career with a Pre Doctoral Fellowship in Pharmacology/Toxicology. The PhRMA Foundation's generosity has been essential to the development of leaders who are passionate about their research. This fellowship will enable me to focus on my project investigating the pharmaco- and toxicogenomics of anticancer agents. Ultimately, I will strive to improve patient care through translational endeavors. Thank you so much for supporting us!

February 1 at 9:48pm